ROTEM monitoring of activated and non-activated prothrombin complex concentrate correction of dilutional coagulopathy

References

• Kozek-Langenecker SA. Influence of fluid therapy on the haemostatic system of intensive care patients. Best Pract Res Clin Anaesthesiol 2009;23:225–36.
   PubMedGoogle Scholar
• Persson J, Grande PO. Volume expansion of albumin, gelatin, hydroxyethyl starch, saline and erythrocytes after haemorrhage in the rat. Intensive Care Med 2005;31:296–301.
   PubMed Web of Science ®Google Scholar
• Niemi TT, Kuitunen AH. Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis. Acta Anaesthesiol Scand 2005;49:373–8.
   PubMed Web of Science ®Google Scholar
• Winstedt D, Hanna J, Schott U. Albumin-induced coagulopathy is less severe and more effectively reversed with fibrinogen concentrate than is synthetic colloid-induced coagulopathy. Scand J Clin Lab Invest 2013;73:161–9.
   PubMed Web of Science ®Google Scholar
• Hickey M, Gatien M, Taljaard M, Aujnarain A, Giulivi A, Perry JJ. Outcomes of urgent warfarin reversal with frozen plasma versus prothrombin complex concentrate in the emergency department. Circulation 2013;128:360–4.
   PubMed Web of Science ®Google Scholar
• Siegal DM, Cuker A. Reversal of novel oral anticoagulants in patients with major bleeding. J Thromb Thrombolysis 2013;35:391–8.
   PubMed Web of Science ®Google Scholar
• Sorensen B, Fries D. Emerging treatment strategies for trauma-induced coagulopathy. Br J Surg 2012;99:40–50.
   PubMed Web of Science ®Google Scholar
• Caballo C, Escolar G, Diaz-Ricart M, Lopez-Vilchez I, Lozano M, Cid J, Pino M, Beltran J, Basora M, Pereira A, Galan AM. Impact of experimental haemodilution on platelet function, thrombin generation and clot firmness: effects of different coagulation factor concentrates. Blood Transfus 2013;11:391–9.
   PubMed Web of Science ®Google Scholar
• Dickneite G, Doerr B, Kaspereit F. Characterization of the coagulation deficit in porcine dilutional coagulopathy and substitution with a prothrombin complex concentrate. Anesth Analg 2008;106:1070–7.
   PubMed Web of Science ®Google Scholar
• Pragst I, Kaspereit F, Dorr B, Dickneite G. Prothrombin complex concentrate (Beriplex P/N) for control of bleeding after kidney trauma in a rabbit dilutional coagulopathy model. Thromb Res 2010;125:272–7.
   PubMed Web of Science ®Google Scholar
• Mitterlechner T, Innerhofer P, Streif W, Lodl M, Danninger T, Klima G, Hansson K, Fries D. Prothrombin complex concentrate and recombinant prothrombin alone or in combination with recombinant factor X and FVIIa in dilutional coagulopathy: a porcine model. J Thromb Haemost 2011;9:729–37.
   PubMed Web of Science ®Google Scholar
• Sorensen B, Spahn DR, Innerhofer P, Spannagl M, Rossaint R. Clinical review: prothrombin complex concentrates – evaluation of safety and thrombogenicity. Crit Care 2011;15:201
   PubMed Web of Science ®Google Scholar
• Awad NI, Cocchio C. Activated prothrombin complex concentrates for the reversal of anticoagulant-associated coagulopathy. P T 2013;38:696–701.
   PubMedGoogle Scholar
• Lindahl TL, Wallstedt M, Gustafsson KM, Persson E, Hillarp A. More efficient reversal of dabigatran inhibition of coagulation by activated prothrombin complex concentrate or recombinant factor VIIa than by four-factor prothrombin complex concentrate. Thromb Res 2015;135:544–7.
   PubMed Web of Science ®Google Scholar
• Turecek PL, Varadi K, Gritsch H, Schwarz HP. FEIBA: mode of action. Haemophilia 2004;10:3–9.
   PubMed Web of Science ®Google Scholar
• Franchini M, Lippi G. Prothrombin complex concentrates: an update. Blood Transfus 2010;8:149–54.
   PubMed Web of Science ®Google Scholar
• Takeyama M, Sakurai Y, Shima M, Matsumoto T, Nogami K, Tanaka I, Takeda T, Giddings JC, Yoshioka A. Heparin-induced inhibitory effects of a prothrombin complex concentrate on global tests of haemostasis. Blood Coagul Fibrinolysis 2007;18:1–7.
   PubMed Web of Science ®Google Scholar
• Scharbert G, Thaler U, Weilnbock C, Wetzel L, Kozek-Langenecker S. Heparin-induced effects of prothrombin complex concentrates in thromboelastometry. Wien Klin Wochenschr 2012;124:32.
   PubMed Web of Science ®Google Scholar
• Hanke AA, Joch C, Gorlinger K. Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): a pharmacovigilance study. Br J Anaesth 2013;110:764–72.
   PubMed Web of Science ®Google Scholar
• Hirsh J, Anand SS, Halperin JL, Fuster V. Mechanism of action and pharmacology of unfractionated heparin. Arterioscler Thromb Vasc Biol 2001;21:1094–6.
   PubMed Web of Science ®Google Scholar
• Hanna J, Winstedt D, Schott U. Fibrinogen and FXIII dose response effects on albumin-induced coagulopathy. Scand J Clin Lab Invest 2013;73:553–62.
   PubMed Web of Science ®Google Scholar
• Schochl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, Kozek-Langenecker S, Solomon C. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010;14:R55.
   PubMed Web of Science ®Google Scholar
• Mittermayr M, Margreiter J, Velik-Salchner C, Klingler A, Streif W, Fries D, Innerhofer P. Effects of protamine and heparin can be detected and easily differentiated by modified thrombelastography (Rotem): an in vitro study. Br J Anaesth 2005;95:310–16.
   PubMed Web of Science ®Google Scholar
• Shenkman B, Einav Y, Livnat T, Budnik I, Martinowitz U. Rotation thromboelastometry analysis of clot formation and fibrinolysis in severe thrombocytopenia: effect of fibrinogen, activated prothrombin complex concentrate, and thrombin-activatable fibrinolysis inhibitor. Int J Lab Hematol 2015;37:521–9.
   PubMed Web of Science ®Google Scholar